Comprehensive analysis of stereotactic Radiosurgery outcomes in triple-negative breast cancer patients with brain metastases: The influence of immunotherapy and prognostic factors
Open Access
- 3 June 2024
- journal article
- research article
- Published by Elsevier in The Breast
- Vol. 76, 103757
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Brain metastasis in de novo stage IV breast cancerThe Breast, 2023
- Brain metastasis in breast cancer: focus on genes and signaling pathways involved, blood–brain barrier and treatment strategiesClinical and Translational Oncology, 2023
- Targeting brain metastases in breast cancerCancer Treatment Reviews, 2022
- Treatment Patterns and Outcomes of Women with Symptomatic and Asymptomatic Breast Cancer Brain Metastases: A Single-Center Retrospective StudyThe Oncologist, 2021
- Impact of breast cancer subtype on clinical outcomes after Gamma Knife radiosurgery for brain metastases from breast cancer: a multi-institutional retrospective study (JLGK1702)Breast Cancer Research and Treatment, 2020
- Treating Brain Metastases from Breast Cancer: Outcomes after Stereotactic RadiosurgeryClinical Oncology, 2020
- The use of stereotactic radiosurgery for brain metastases from breast cancer: Who benefits most?Breast Cancer Research and Treatment, 2015
- Treatment outcomes and prognostic factors for patients with brain metastases from breast cancer of each subtype: a multicenter retrospective analysisBreast Cancer Research and Treatment, 2014
- Sites of distant recurrence and clinical outcomes in patients with metastatic triple‐negative breast cancerCancer, 2008
- Stereotactic Radiosurgery Plus Whole-Brain Radiation Therapy vs Stereotactic Radiosurgery Alone for Treatment of Brain MetastasesJAMA, 2006